Tandem Diabetes Care (TNDM) Change in Cash (2013 - 2026)
Tandem Diabetes Care's (TNDM) quarterly Change in Cash came in at -$116.5 million in Q2 2026, down 1205.59% on a YoY basis from $10.5 million in Q2 2025, and down 231.36% quarter-over-quarter from $88.7 million in Q1 2026.
Analysis
Tandem Diabetes Care (TNDM) Change in Cash (2013 - 2026) Analysis & Trends
Tandem Diabetes Care (TNDM) has reported Change in Cash for 14 consecutive years, with -$116.5 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Change in Cash fell 1205.59% year-over-year to -$116.5 million; the trailing twelve-month figure through Jun 2026 stood at -$1.3 million (down 107.88% YoY), and the FY2025 full-year result was $21.4 million, up 106.44% from the prior year.
- Change in Cash eased to -$116.5 million in Q2 2026 per TNDM's latest filing, from $88.7 million in the prior quarter.
- Across five years, Change in Cash topped out at $88.7 million in Q1 2026 and bottomed at -$116.5 million in Q2 2026.
- Historically, Change in Cash has averaged -$464611.1 across 5 years, with a median of $2.2 million in 2023.
- The widest YoY moves for Change in Cash: up 1974.14% in 2025, down 14208.11% in 2025.
- Over 5 years, Change in Cash stood at $48.7 million in 2022, then tumbled by 142.57% to -$20.7 million in 2023, then surged by 197.36% to $20.2 million in 2024, then slumped by 106.5% to -$1.3 million in 2025, then slumped by 8773.34% to -$116.5 million in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered -$116.5 million, $88.7 million, and -$1.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.84 Bn | 174.23 Bn | 7.27 Bn | -1.70 Bn |
| 2 | Intuitive Surgical | 128.02 Bn | 122.81 Bn | 1.96 Bn | 753.60 Mn |
| 3 | Medtronic | 117.28 Bn | 108.46 Bn | 6.34 Bn | -258.00 Mn |
| 4 | Stryker | 103.92 Bn | 100.44 Bn | 4.50 Bn | 513.00 Mn |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn | -890.00 Mn |
| 6 | Edwards Lifesciences | 49.96 Bn | 45.70 Bn | 1.35 Bn | 462.20 Mn |
| 7 | Alcon | 32.86 Bn | 31.40 Bn | 1.68 Bn | -223.00 Mn |
| 8 | Dexcom | 32.25 Bn | 30.30 Bn | 830.00 Mn | -13.20 Mn |
| 9 | Steris | 20.74 Bn | 20.26 Bn | 684.20 Mn | 42.80 Mn |
| 10 | Tandem Diabetes Care | 1.26 Bn | 808.29 Mn | 144.78 Mn | -116.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -116.51 Mn |
| Mar 31, 2026 | 88.69 Mn |
| Dec 31, 2025 | -1.31 Mn |
| Sep 30, 2025 | 27.84 Mn |
| Jun 30, 2025 | 10.54 Mn |
| Mar 31, 2025 | -15.66 Mn |
| Dec 31, 2024 | 20.20 Mn |
| Sep 30, 2024 | 1.34 Mn |
| Jun 30, 2024 | -11.28 Mn |
| Mar 31, 2024 | 111,000.00 |
| Dec 31, 2023 | -20.74 Mn |
| Sep 30, 2023 | -51.14 Mn |
| Jun 30, 2023 | 2.99 Mn |
| Mar 31, 2023 | -44.76 Mn |
| Dec 31, 2022 | 48.73 Mn |
| Sep 30, 2022 | 8.82 Mn |
| Jun 30, 2022 | 21.29 Mn |
| Mar 31, 2022 | 22.50 Mn |
| Dec 31, 2021 | -41.19 Mn |
| Sep 30, 2021 | 13.80 Mn |